Pu Xu, Yan Li, Su Zhou, Ziqi He, You Yang, Hua Yu. Human RBC alloimmunization evaluation after exposure to foreign E antigen of the rhesus system in transfusion[J]. Blood&Genomics, 2017, 1(1): 37-42. DOI: 10.46701/APJBG.20170116009
Citation: Pu Xu, Yan Li, Su Zhou, Ziqi He, You Yang, Hua Yu. Human RBC alloimmunization evaluation after exposure to foreign E antigen of the rhesus system in transfusion[J]. Blood&Genomics, 2017, 1(1): 37-42. DOI: 10.46701/APJBG.20170116009

Human RBC alloimmunization evaluation after exposure to foreign E antigen of the rhesus system in transfusion

More Information
  • Available Online: 2021-06-29
  • Anti-E alloantibody has been one of the most frequently detected clinically significant alloantibodies in previous studies. Red blood cell (RBC) transfusion is unique in its common intravenous introduction of foreign E antigen and provides a valuable opportunity to study the human immunologic response to intravenous foreign E antigen. Patients exposed to foreign E antigen while receiving RBC transfusions are at risk of forming anti-E alloantibody. Valid estimates of anti-E alloimmunization risk are clinically important, but the forming mechanism of anti-E alloimmunization remains unclear. Here, we screened 516 inpatients at risk of exposure to foreign E antigen while receiving RBC transfusions and monitored the development of anti-E alloantibody for up to two years after left hospital. However, only 2 cases of anti-E alloimmunization were identified in this study. Patients who received RBC transfusion had a very high risk of exposure to foreign E antigen, but the anti-E alloantibody production incidence was very low and few anti-E alloantibodies were produced within 3 to 6 months after RBC transfusion in this study. Further research would contribute to our knowledge of the anti-E alloimmunization mechanism and prevent anti-E development, which would be significantly useful in clinical for transfusions, obstetric management, and the evaluation and management of transfusion reactions in laboratory and institutional resources and cost reduction in healthcare system.
  • Related Articles

    [1]Shichun Wang, Qi Liu, Yahan Fan, Yanhong Xin, Shan Wang, Jie Yan, Chunyan Yao. Thromboelastography for Diagnosing Coagulopathy and Guiding Blood Transfusion[J]. Blood&Genomics, 2024, 8(2): 10001. DOI: 10.70322/BG20240210001
    [2]Shuming Zhao, Hongjun Gao. Practice of Clinical Transfusion Medicine, 2nd Edition[J]. Blood&Genomics, 2024, 8(1): 10010. DOI: 10.70322/BG20240110010
    [3]Xiangyan Huang. Management and cause analysis of platelet transfusion refractoriness[J]. Blood&Genomics, 2018, 2(4): 217-222. DOI: 10.46701/APJBG.2018042018134
    [4]Ying Cui, Rujuan Bao, Shijie Mu. Transfusion-associated microchimerism in traumatic patients[J]. Blood&Genomics, 2018, 2(3): 137-140. DOI: 10.46701/APJBG.2018032018121
    [5]Xiaochuan Song, Bin Liu, YujiaoLi, Min Ju, Jie Xu. Sero-prevalence of RBC alloantibodies among Han and minority patients in Xinjiang[J]. Blood&Genomics, 2017, 1(3): 25-28. DOI: 10.46701/APJBG.2017032017033
    [6]Zhenzhen Zhou, Dan Xu, Ling Sun, Jiongcai Lan. The progress in pre-transfusion test technique research[J]. Blood&Genomics, 2017, 1(3): 7-12. DOI: 10.46701/APJBG.2017032017039
    [7]Shuhong Yu, Jie Xiao, Hong Xu, Yushiang Lin, Jhysheng Chang, Yanbin Li, Dezhen Gao, Shuai Pang, Zhiyuan Xu, Tianhong Miao. The best strategy of blood transfusion in patients with Rhnull syndrome[J]. Blood&Genomics, 2017, 1(2): 71-74. DOI: 10.46701/APJBG.20170217026
    [8]Xiaohua Tu, Yan Zang, Haihui Gu, Huijun Guo, Xin Ye, Zhanshan Cha, Baohua Qian. Perioperative blood transfusion is associated with poorer survival in patients with gastric cancer[J]. Blood&Genomics, 2017, 1(2): 7-13. DOI: 10.46701/APJBG.20170217024
    [9]Jiangcun Yang, Qiushi Wang, Yang Sun, Ting Ma, Shuming Zhao, Bijuan Li, Cuixiang Xu, Hang Chen, Ziyun Shi, Jing Liu. Investigation of the status quo of massive blood transfusion in China[J]. Blood&Genomics, 2017, 1(1): 25-36. DOI: 10.46701/APJBG.20170116013
    [10]Meng Gao, Rong Huang, Hao Tang, Yunfeng Fu, Fengxia Liu, Rong Gui. A Chinese perspective on factors and molecular mechanisms that influence the curative effects of platelet transfusion[J]. Blood&Genomics, 2017, 1(1): 11-16. DOI: 10.46701/APJBG.20170116014

Catalog

    Article Metrics

    Article views (1831) PDF downloads (1154) Cited by()
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return